Anaemia predicts mortality in heart failure;La anemia es un factor pronóstico de mortalidad en la insuficiencia cardiaca

Anales de Medicina Interna

Volumn 22, Issue 6, 2005, Pages 271-274

  García De Casasola, Gonzalo ^a,b   Cardenas Franco C ^a   Vegas Serrano, A ^a   Hornero Izquierdo, M A ^a   Guijarro Herraiz, C ^a   Zapatero Gaviria, A ^a  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^b NONE   (Spain)

Author keywords

Anaemia; Congestive; Heart failure; Hospital mortality; Kidney failure

Indexed keywords

CREATININE; HEMOGLOBIN;

AGE; AGED; ANEMIA; ARTICLE; CREATININE BLOOD LEVEL; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; PREVALENCE; RISK FACTOR; SPAIN;

AGED; AGED, 80 AND OVER; ANEMIA; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 23644436688     PISSN: 02127199     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Parsi A, Kleber FX. Anaemia in heart failure: its diagnosis and management. Eur J Heart Fail 2003; 5: 3-4.
2. Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003; 107: 223-225.
3. Horwich TB, Fonarow GC, Hamilton MA, MacLellan WR, Borenstein J. Anemia is associated with worse symptoms, greater impairment in functional capacity and a significant increase in mortality in patients with advanced heart failure. J Am Coll Cardiol 2002; 39: 1780-1786.
4. McClellan WM, Flanders WD, Langsten RD, Jurkovitz C, Presley R. Anemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospitals: a population-based study. J Am Soc Nephrol 2002; 13: 1928-1936.
5. Silverberg DS, Wexler D, Iaina A. The importance of anemia and its correction in the management of severe congestive heart failure. Eur J Heart Fail 2002; 4: 681-686.
6. Urrutia A, Lupón J, González B, Parajón T, Altimir S, Coll R et al. Anemia y paramétras relacionados en pacientes de una unidad de insuficiencia cardiaca multidisciplinaria. Med Clin (Barc) 2004; 122: 121-125.
7. Androne AS, Katz SD, Lund L, LaManca J, Hudaihed A, Hryniewicz K et al. Hemodilution is common in patients with advanced heart failure. Circulation 2003; 107: 226-229.
8. Nissenson AR, Goodnough LT, Dubois RW. Anemia: not just an innocent bystander? Arch Intern Med 2003; 163: 1400-1404.
9. Szachniewicz J, Petruk-Kowalczyk J, Majda J, Kaczmarek A, Reczuch K, Kalra PR et al. Anaemia is an independent predictor of poor outcome in patients with chronic heart failure. Int J Cardiol 2003; 90: 303-308.
10. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 2003; 114: 112-119.
11. Mozaffarian D, Nye R, Levy WC. Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE). J Am Coll Cardiol 2003; 41: 1933-1939.
12. Felker GM, Gattis WA, Leimberger JD, Adams KF, Cuffe MS, Gheorghiade M et al. Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. Am J Cardiol 2003; 92: 625-628.
13. Kalra PR, Collier T, Cowie MR, Fox KF, Wood DA, Poole-Wilson PA et al. Haemoglobin concentration and prognosis in new cases of heart failure. Lancet 2003; 362: 211-212.
14. Sharma R, Coats AJS, Anker SD. The role of inflammatory mediators in chronic heart failure: cytokines, nitric oxide, and endothelin-1. Int J Cardiol 2000; 72: 175-186.
15. Silverberg D, Wexler D, Blum M, Wollman Y, Iaina A. The cardio-renal anaemia syndrome: does it exist? Nephrol Dial Transplant 2003; 18 (Suppl 8): 7-12.
16. Caramelo C, Gil P. Insuficiencia combinada cadiorrenal: una entidad emergente. Med Clin (Barc) 2003; 121: 710-717.
17. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A et al. The effect of spironolactone on morbidity and mortality in patients with sever heart failure. N Engl J Med 1999; 341: 709-717.
18. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351: 543-551.
19. Kalra PR, Bolger AP, Francis DP, Genth-Zotz S, Sharma R, Ponikowski PP et al. Effect of anemia on exercise tolerance in chronic heart failure in men. Am J Cardiol 2003; 91: 888-891.
20. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E et al. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000; 35: 1737-1744.
21. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R et al. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001; 37: 1775-1780.
22. Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G et al. The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transplant 2003; 18: 141-146.
23. Jones M, Ibels L, Schenkel B, Zagari M. Impact of epoetin alfa on clinical end points in patients with chronic renal failure: analysis. Kidney Int 2004; 65: 757-767.